SCHEMBL1084306

SCHEMBL1084306

CN1CCN(c2ccccc2-c2nc(N(C)C)c3ccccc3n2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 10/20 0.58
CYP1A2 P05177 10/20 0.58
TSHR P16473 8/20 0.58
MAPK1 P28482 5/20 0.58
CYP2C19 P33261 4/20 0.58
CLK4 Q9HAZ1 3/20 0.58
CYP3A4 P08684 8/20 0.54
ALDH1A1 P00352 6/20 0.54
HSD17B10 Q99714 5/20 0.54
LMNA P02545 4/20 0.54
ALOX15 P16050 3/20 0.54
TP53 P04637 2/20 0.54
USP2 O75604 2/20 0.54
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 2/20 0.54
CYP2C9 P11712 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083873 0.90 CYP2D6 (0.60) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1084304 0.89 CYP2D6 (0.59) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1084177 0.86 HRH4 (0.65) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1084143 0.76 HTR3A (0.52) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1084235 0.75 HTR3A (0.51) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL937501 0.73 CYP2D6 (0.70) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1084245 0.73 CYP2D6 (0.70) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL939168 0.73 CYP2D6 (0.70) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1083911 0.73 CYP2D6 (0.70) CYP2D6CYP1A2TSHRMAPK1CYP2C19
SCHEMBL1083829 0.73 CYP2D6 (0.70) CYP2D6CYP1A2TSHRMAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed